| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Diabetes mellitus (BASKET)VanadiumDiabetes mellitus (Dermatology)ObesityOrlistatReceptor (Free fatty acids)Regeneration of tissues and other biologic structuresbeta cell (Pancreas)LipotoxicityEndothelial dysfunctionPARPRAAS (Angiotensin converting enzyme 2)Histone deacetylase| 1 | 2002 | Chronic complications of diabetes. | 
| + | - | nl | South Med J 95(1):30-4 (2002) |
| 2 | 2008 | A systematic review of vanadium oral supplements for glycaemic control in type 2 diabetes mellitus. |
| + | - | nl | QJM 101(5):351-8 (2008) |
| 3 | 2006 | Pathophysiology and management of recurrent hypoglycaemia and hypoglycaemia unawareness in diabetes. |
| + | - | nl | Neth J Med 64(8):269-79 (2006) |
| 4 | 2008 | Skin manifestations of diabetes. | 
| + | - | nl | Cleve Clin J Med 75(11):772, 774, 776-7 passim (2008) |
| 5 | 2009 | Angiotensin blockade to reduce microvascular damage in diabetes mellitus. |
| + | - | nl | Dtsch Arztebl Int 106(34-35):556-62 (2009) |
| 6 | 2008 | Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers. |
| + | - | nl | Vasc Health Risk Manag 4(3):575-96 (2008) |
| 7 | 2008 | Orlistat in the prevention of diabetes in the obese patient. |
| + | - | nl | Vasc Health Risk Manag 4(2):325-36 (2008) Mancini MC |
| 8 | 1960 | Methods of studying antidiabetic substances--a review. |
| + | - | nl | Indian J Physiol Pharmacol 4(-):1-16 (1960) |
| 9 | 2009 | Can Roux-en-Y gastric bypass provide a lifelong solution for diabetes mellitus? |
| + | - | nl | Can J Surg 52(6):E269-75 (2009) |
| 10 | 1998 | A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? |
| + | - | nl | Ann Surg 227(5):637-43; discussion 643-4 (1998) |
| 11 | 2003 | Guidelines for the detection of diabetes mellitus--diagnostic criteria and rationale for screening. |
| + | - | nl | Clin Biochem Rev 24(3):77-80 (2003) |
| 12 | 2003 | Treatment of diabetic ketoacidosis in children and adolescents. |
| + | - | nl | Acta Biomed 74(2):59-68 (2003) |
| 13 | 2002 | Mitochondrial factors in the pathogenesis of diabetes: a hypothesis for treatment. |
| + | - | nl | Altern Med Rev 7(2):94-111 (2002) |
| 14 | 2010 | Autophagy in health and disease. 4. The role of pancreatic beta-cell autophagy in health and diabetes. |
| + | - | nl | Am J Physiol Cell Physiol 299(1):C1-6 (2010) |
| 15 | 2008 | Seven transmembrane-spanning receptors for free fatty acids as therapeutic targets for diabetes mellitus: pharmacological, phylogenetic, and drug discovery aspects. |
| + | - | nl | J Biol Chem 283(24):16269-73 (2008) |
| 16 | 2009 | Stem cells to pancreatic beta-cells: new sources for diabetes cell therapy. |
| + | - | nl | Endocr Rev 30(3):214-27 (2009) |
| 17 | 2008 | Glucolipotoxicity: fuel excess and beta-cell dysfunction. |
| + | - | nl | Endocr Rev 29(3):351-66 (2008) |
| 18 | 2005 | Regulation of pancreatic beta-cell mass. |
| + | - | nl | Physiol Rev 85(4):1255-70 (2005) |
| 19 | 2002 | Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. |
| + | - | nl | Clin Chem 48(3):436-72 (2002) |
| 20 | 2005 | Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme. |
| + | - | nl | Antioxid Redox Signal 7(11-12):1568-80 (2005) |
| 21 | 2007 | The use of oral antidiabetic agents in primary care. |
| + | - | nl | Aust Fam Physician 36(6):477-80 (2007) |
| 22 | 2010 | Diabetes mellitus classification. |
| + | - | nl | Arq Bras Cardiol 95(2):e40-6 (2010) |
| 23 | 2009 | The sweeter side of ACE2: physiological evidence for a role in diabetes. |
| + | - | nl | Mol Cell Endocrinol 302(2):193-202 (2009) |
| 24 | 2010 | Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus. | 
| + | - | nl | Mediators Inflamm 2010(-):792393 (2010) |
| 25 | 2010 | Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. |
| + | - | nl | Mediators Inflamm 2010(-):453892 (2010) |
| 26 | 2011 | Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus. |
| + | - | nl | Mol Med 17(5-6):378-90 (2011) |
| 27 | 2010 | The role of epigenetics in the pathology of diabetic complications. |
| + | - | nl | Am J Physiol Renal Physiol 299(1):F14-25 (2010) |
